Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

2,6-diisopropylphenyl-4-hydroxybutanote disodium phosphate

Known as: HX0969w 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Background Propofol is the most widely used intravenous sedative-hypnotic anesthetic in clinical practice. However, many serious… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • table 3
2015
2015
OBJECTIVE To estimate the median effective dose (EDs0) of oral administrated HX0969w, fospropofol disodium and propofol emulsion… Expand
2014
2014
BACKGROUND:Phosphate ester prodrugs of propofol (fospropofol, HX0969W) were designed to avoid the unsatisfactory water solubility… Expand
  • figure 1
  • figure 3
  • figure 4
  • figure 5
  • table 1
2014
2014
• Volume 118 • Number 4 www.anesthesia-analgesia.org 745 As a commonly used IV sedative hypnotic drug, propofol has rapid onset… Expand
  • figure 1
  • figure 3
  • figure 4
  • figure 5
  • table 1
2013
2013
BACKGROUND HX0969w is a novel water-soluble prodrug designed to release propofol and gamma-hydroxybutyrate (GHB) and has a… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
2013
2013
The water-soluble derivatives of propofol have gained attention as a method to increase solubility of propofol. According to the… Expand
  • table 1
  • figure 6
  • figure 1
  • table 2
  • figure 4
2012
2012
OBJECTIVE To examine the effects of a new intravenous anesthetic HX0969w on spontaneous locomotor activity in mice.METHODS 60… Expand
2011
2011
HX0969w is a novel carboxylate ester prodrug of propofol. After intravenous administration of HX0969w, the compound is rapidly… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • table 2